Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction

Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction

Abstract Aims Current evidence about the effect of angiotensin receptor blocker (ARB) on the outcome of heart failure with mid‐range ejection fraction (HFmrEF) is lacking. We aim to assess the association between use of ARB and 1 year all‐cause mortality after hospitalization for HFmrEF. Methods and...

Full description

Bibliographic Details
Main Authors: Bin Wang, Lihua Zhang, Shuang Hu, Xueke Bai, Xi Li, Jing Li, Xin Zheng
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:ESC Heart Failure
Subjects:
Angiotensin receptor blocker
Heart failure with mid‐range ejection fraction
Mortality
Online Access:https://doi.org/10.1002/ehf2.13229

Similar Items

Similar Items